Phase 3 Refractory Acute Myeloid Leukemia Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia
Relapsed or Refractory Acute Myeloid Leukemia
Shanxi Bethune Hospital50 enrolled1 locationNCT05726110
Recruiting
Phase 3
IMPACT-AML: Randomized Pragmatic Clinical Trial for Relapsed or Refractory AML
Refractory Acute Myeloid LeukemiaEarly Relapses of Acute Myeloid Leukemia
National Research Center for Hematology, Russia198 enrolled1 locationNCT06418776